冠状动脉血管炎:一个让皮肤冠状动脉干预复杂的梦
Tianhao Zhang1, Juan Du2, Hongkai Zhang3
1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
JACC. Case reports
|September 26, 2025
概括
冠状动脉血管炎 (CAV) 是一种罕见的心脏病的原因,可以使支架复杂化. 冠状动脉计算机断层扫描血管学有助于区分CAV与动脉样硬化冠状动脉疾病 (CAD).
科学领域:
- 心脏病学 心脏病学
- 放射学 放射学是一门学科.
- 免疫学 免疫学 免疫学
背景情况:
- 冠状动脉血管炎 (CAV) 是冠状动脉疾病 (CAD) 的不常见原因之一.
- 从临床上来说,将CAV与动脉样硬化CAD区分开来是具有挑战性的.
- CAV会导致复发性并发症,特别是在冠状动脉支架放置后.
研究的目的:
- 描述诊断为CAV的患者的临床和成像特征.
- 提高对潜在的CAV误诊的认识.
- 突出及时诊断和专用成像分析对CAV的重要性.
主要方法:
- 一个由10名症状患者组成的病例系列,最初怀疑患有动脉样硬化CAD,但诊断为CAV.
- 从2021年8月到2024年10月的临床和成像数据的分析.
- 冠状动脉计算机断层扫描血管图 (CCTA) 用于详细评估.
主要成果:
- 该案例系列确定了CCTA的一些经典的CAV特征.
- 这些特征有助于区分CAV和动脉样硬化CAD.
- 这些发现强调了诊断CAV的挑战.
结论:
- 冠状动脉计算机断层扫描血管学提供了对斑块特征,冠状动脉壁异常和冠状动脉周围炎症的全面洞察.
- CCTA的发现可以帮助心脏病学家和放射学家区分CAV和动脉样硬化CAD.
- 及时诊断和专门的成像分析对于管理CAV至关重要.
相关概念视频
Coronary Artery Disease V: Interprofessional Care
215
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215
Pericarditis I: Introduction
336
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
336
Acute Coronary Syndrome IV: Interprofessional Care
220
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
220
Acute Coronary Syndrome III: Diagnostic Studies
215
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
215
Acute Coronary Syndrome I: Introduction
812
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
812
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
361
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
361


